ALLEN ROBERT D. III (Chief Scientific Officer) sold 17.4% of their position (37.72K shares) of INVIVYD, INC. on the open market
Open‑market sale worth $29.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/19/2026ACC: 0001193125-26-355911
Officer· Chief Scientific Officer
Since Feb 2026
-37.72K
Net shares
Net seller
$29.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
102K acquired · 139.72K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+102K
Price / share
—
Trade value
—
% of position
89.1%
8/15/2026
114.49K→216.49K
Common Stock
Direct
Shares
−20.68K
Price / share
$0.72
Trade value
$14.93K
% of position
9.6%
8/17/2026
216.49K→195.81K
Common Stock
Direct
Shares
−17.04K
Price / share
$0.84
Trade value
$14.37K
% of position
8.7%
8/18/2026
195.81K→178.76K
Total
Net shares
+64.28K
Net value
-$29.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2026 | M · Option Exercise | +102K | — | — | 89.1% | 114.49K | 216.49K |
| Common Stock Direct | 8/17/2026 | S · Sale | −20.68K | $0.72 | $14.93K | 9.6% | 216.49K | 195.81K |
| Common Stock Direct | 8/18/2026 | S · Sale | −17.04K | $0.84 | $14.37K | 8.7% | 195.81K | 178.76K |
| Total | +64.28K | -$29.30K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
102K shares
Shares
−102K
Strike price
Held after
0.00
Exercisable
—
8/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock102K shares | 8/15/2026 | M · Option Exercise | −102K | — | 0.00 |